Autologous bone marrow-derived stem cells

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	2

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03067857 (ClinicalTrials.gov)	September 2016	25/2/2017	Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease	Autologous Purified Bone-Marrow-Derived Stem Cell Therapy for Motor Neuron Disease	Motor Neuron Disease;Amyotrophic Lateral Sclerosis;Primary Lateral Sclerosis;Progressive Muscular At ...	Biological: Stem Cells	Stem Cells Arabia	NULL	Unknown status	24 Years	70 Years	All	40	Phase 1/Phase 2	NULL
2	NCT01082653 (ClinicalTrials.gov)	March 2010	1/3/2010	Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis	Phase I, Single Center, Prospective, Non-randomized, Open Label, Safety/Efficacy Study of the Infusi ...	Amyotrophic Lateral Sclerosis	Biological: autologous bone marrow-derived stem cells	TCA Cellular Therapy	NULL	Suspended	18 Years	80 Years	Both	6	Phase 1	United States

First Previous1Next Last